Insiders Updates
A company insider recently sold 79,220 shares of Kymera Therapeutics Inc [KYMR]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s filing revealed that its Chief Financial Officer Jacobs Bruce N. unloaded Company’s shares for reported $3.96 million
Kymera Therapeutics Inc’s filing revealed that its Chief Financial Officer Jacobs Bruce N. unloaded Company’s shares for reported $3.96 million
Kymera Therapeutics Inc’s recently made public that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million
Kymera Therapeutics Inc’s filing revealed that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million on
Kymera Therapeutics Inc’s recent filing unveils that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million
In a filing, Kymera Therapeutics Inc revealed its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kymera Therapeutics Inc’s filing revealed that its Director BVF PARTNERS L P/IL acquired Company’s shares for reported $13.96 million on